ISS is a biotech dedicated to the production, valorization and commercialization of seaweed extracts for human and animal nutraceuticals, F&B and cosmetic industries. The company brings innovative, healthy and sustainable solutions with a global positive impact in the economy, society and the environment, thus supporting its ambition to act as a Benefit Corporation while being "Ínclita inside".
ISS arose based on the work developed by two CIIMAR researchers in the field of algal biotechnology and with the joint vision and know-how of the two other partners experienced in business and innovation , being granted the title of the 1st spin-off of CIIMAR.
ISS has a well-defined B2B business model: to develop as a CRO , produce and license or commercialize seaweed extracts, addressing customer unmet needs, while enhanced by own IP and through on developing AI based toolbox for customer-centric solutions, in an agile and iterative manner . This enables differentiation in the market an...
ISS is a biotech dedicated to the production, valorization and commercialization of seaweed extracts for human and animal nutraceuticals, F&B and cosmetic industries. The company brings innovative, healthy and sustainable solutions with a global positive impact in the economy, society and the environment, thus supporting its ambition to act as a Benefit Corporation while being "Ínclita inside".
ISS arose based on the work developed by two CIIMAR researchers in the field of algal biotechnology and with the joint vision and know-how of the two other partners experienced in business and innovation , being granted the title of the 1st spin-off of CIIMAR.
ISS has a well-defined B2B business model: to develop as a CRO , produce and license or commercialize seaweed extracts, addressing customer unmet needs, while enhanced by own IP and through on developing AI based toolbox for customer-centric solutions, in an agile and iterative manner . This enables differentiation in the market and allows for premium value opportunities. On the long run, ISS intends to design, pilot and build a bio-refinery in order to utilize all the seaweed biomass in multiple value-added solutions for the human and animal nutraceuticals, F&B, cosmetic and possibly, pharmaceutical industries, with positive impacts in the economy and the society.
More information
+3

Employees

Ana Catarina Guedes
Admin
Ana Catarina Guedes CTO Algal Biotechnology Researcher